J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve
Johnson & Johnson JNJ recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. Following this deal, JNJ joins several other large-cap pharma companies that signed similar deals with the government in 2025. These companies include Amgen, Bristol Myers, privately-held Boehringer Ingelheim, Genentech (a member of the Roche Group), Gilead Sciences, GSK […]
Amylyx selects AMX-0318 as development candidate
Amylyx Pharmaceuticals Inc. has nominated AMX-0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development candidate for post-bariatric hypoglycemia and other rare diseases.
Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond
2025 was a tumultuous year for the global healthcare sector. For much of the year, policy uncertainty, particularly around U.S. drug pricing and trade barriers, weighed heavily on valuations, which reached near 30-year lows (as mentioned by a BlackRock report). However, a dramatic shift occurred in the final quarter. The sector rebounded strongly, led by […]
THE WORLD IS FLAT FAT: More than a quarter of adults worldwide could benefit from GLP-1 medications
THE WORLD IS FLAT FAT: More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds.
Prior Authorization Team Lead
A company is looking for a Prior Authorization Team Lead to oversee prescription prior authorization operations. Key Responsibilities Lead and manage prescription prior authorization operations, ensuring accuracy and timely approvals Own the end-to-end prior authorization process, including intake, submission, follow-up, and resolution Serve as the primary operational contact for the BPO partner, overseeing productivity and […]
NutraCast: Is fiber the new protein?
COMET’s new trend report examines why consumers are tapping into functional foods over supplements for fiber, how GLP-1 users are driving prebiotic adoption and why diverse fiber formulations outperform single-prebiotic strategies.
What’s going on with Tesco shares?
Shares in Tesco (LSE:TSCO) fell 7% on Thursday (8 January) after the company reported weak Christmas sales. The big issue for investors is why this has been happening. GLP-1s Tesco reported like-for-like sales growth of 2.4% over the Christmas period. Thatâs below the level of inflation and represents a disappointing result. One potential reason for […]
Mounjaro: Experts issue warning over black market jabs, with fifth of areas still lacking NHS access
One in five local areas in England still do not provide the weight loss jab tirzepatide (Mounjaro) on the NHS six months after the drug was supposed to be rolled out across the country, The BMJ has found.Although progress has been made since The BMJ reported that last summer less than half of England’s integrated […]
Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis
(MedPage Today) — Note that some links may require registration or subscription. Doctors debunked five women’s health myths on mammograms, menopause, exercise, and more. (NPR) The FDA rejected tasimelteon (Hetlioz) as a treatment for jet lag…
Food Exec Brief: Food Fraud’s $77B Crisis, 2026’s Regulatory Reckoning, and AI’s Value Revolution
Welcome to this week’s Food Exec Brief, your strategic intelligence roundup covering AI’s evolution from efficiency tool to value creator, the explosive growth of food fraud threatening global supply chains, and the regulatory tsunami reshaping everything from dietary guidelines to ultra-processed food definitions as we navigate 2026’s transformational landscape. Key takeaways: Food fraud surges to […]